In the News
Insulin pumps can treat poorly controlled type 2 diabetes, trial finds
Insulin pumps may be a useful treatment in patients who have poorly controlled type 2 diabetes despite multiple daily insulin injections, a new trial indicates.
Sitagliptin may be associated with more heart failure-related hospitalizations
Sitagliptin was associated with an increased risk of heart failure hospitalizations in patients with diabetes and preexisting heart failure, a study found.
Bionic and artificial pancreas systems found effective in real-life settings
Recent tests of artificial pancreas systems have found that the technology could provide better glucose control for patients with type 1 diabetes than current care does.
MKSAP quiz: Leg pain and numbness
This month's quiz asks readers to evaluate a patient with diabetes, back and thigh pain, and difficulty walking.
In overweight or obese patients with diabetes, a lifestyle intervention increased weight loss at 8 years
Receiving an intensive lifestyle intervention (ILI) rather than traditional diabetes support and education (DSE) increased weight loss in about 5,000 middle-aged adults with type 2 diabetes.
Diabetes Collaborative Registry provides seamless view of diabetes patients across specialties
The American College of Cardiology, in partnership with the American Diabetes Association, the American College of Physicians, and Joslin Diabetes Center, has launched the Diabetes Collaborative Registry.
Inhaled insulin approved
Afrezza, a rapid-acting, inhaled human insulin, was recently approved by the FDA to treat diabetes in adults.
Olmesartan passes safety review
The benefits of the angiotensin-receptor blocker olmesartan continue to outweigh the risks for diabetic patients, according to the FDA.
Spotlight on psychological impacts
Managing diabetes can negatively impact quality of life for people with the disease, so doctors should consider a patient's treatment burden and the “whole person” when setting goals, 2 studies suggest.